Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New House Oversight Panel Chair Towns Less Combative With Drug Industry

Executive Summary

Drug companies likely will face less combative investigations into their activities by the House Oversight and Government Reform Committee during the 111 Congress

You may also be interested in...



GOP Players In Health Debate: McCain To HELP; Enzi Adds Finance To Resume

In the face of substantially higher Democratic congressional majorities, two Republican senators have ensured their place in the debate over health care reform and providing Americans with access to safe medicines

GOP Players In Health Debate: McCain To HELP; Enzi Adds Finance To Resume

In the face of substantially higher Democratic congressional majorities, two Republican senators have ensured their place in the debate over health care reform and providing Americans with access to safe medicines

PhRMA’s Revised DTC Code Shies Away From Internet; Not Celebrities

The Pharmaceutical Research and Manufacturers of America's revised guidelines for direct-to-consumer advertising steer clear of the Internet, even as drug ads are a growing presence on the Web

Topics

UsernamePublicRestriction

Register

MT142639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel